
Dare Bioscience Inc
NASDAQ:DARE

Intrinsic Value
The intrinsic value of one
DARE
stock under the Base Case scenario is
17.32
USD.
Compared to the current market price of 3.03 USD,
Dare Bioscience Inc
is
Undervalued by 83%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Dare Bioscience Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Dare Bioscience Inc
Balance Sheet Decomposition
Dare Bioscience Inc
Current Assets | 11.8m |
Cash & Short-Term Investments | 10.3m |
Receivables | 105.2k |
Other Current Assets | 1.4m |
Non-Current Assets | 6.8m |
PP&E | 5.7m |
Other Non-Current Assets | 1.1m |
Free Cash Flow Analysis
Dare Bioscience Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Dare Bioscience Inc
Revenue
|
89.6k
USD
|
Cost of Revenue
|
7.6k
USD
|
Gross Profit
|
97.2k
USD
|
Operating Expenses
|
-1.7m
USD
|
Operating Income
|
-1.6m
USD
|
Other Expenses
|
-45.7k
USD
|
Net Income
|
-1.7m
USD
|
DARE Profitability Score
Profitability Due Diligence
Dare Bioscience Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Score
Dare Bioscience Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
DARE Solvency Score
Solvency Due Diligence
Dare Bioscience Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Score
Dare Bioscience Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DARE Price Targets Summary
Dare Bioscience Inc
According to Wall Street analysts, the average 1-year price target for
DARE
is 13.26 USD
with a low forecast of 12.12 USD and a high forecast of 14.7 USD.
Dividends
Current shareholder yield for DARE is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
DARE
stock under the Base Case scenario is
17.32
USD.
Compared to the current market price of 3.03 USD,
Dare Bioscience Inc
is
Undervalued by 83%.